ANN HENDERSON: Open Payments
NPI 1720054620 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,876 in 42 payments from 23 companies in 2025. Trend: 2023 $4,545 · 2024 $2,220 · 2025 $1,876
Food & beverage: $1,798Education: $78
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $290 |
| Sage Therapeutics, LLC | 2 | $174 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $120 |
| Neurocrine BioSciences, Inc. | 1 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $108 |
| Alexion Pharmaceuticals, Inc. | 1 | $105 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Insmed, Inc. | 1 | $93 |
Products named: NEFFY, LYBALVI, INGREZZA, RYBREVANT, STRENSIQ, TALVEY, Auvelity, Arikayce.
Industry payments across MD — which companies pay providers there.
